Cargando…

Alteration of the α-Synuclein Folding Landscape by a Mutation Related to Parkinson’s Disease**

Detalles Bibliográficos
Autores principales:	Ferreon, Allan Chris M, Moran, Crystal R, Ferreon, Josephine C, Deniz, Ashok A
Formato:	Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2010
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972640/ https://www.ncbi.nlm.nih.gov/pubmed/20544898 http://dx.doi.org/10.1002/anie.201000378

Ejemplares similares

Modulation of allostery by protein intrinsic disorder
por: Ferreon, Allan Chris M., et al.
Publicado: (2013)

Direct Single-Molecule Observation of Sequential DNA Bending Transitions by the Sox2 HMG Box
por: Moosa, Mahdi Muhammad, et al.
Publicado: (2018)

Aggregation of Disordered Proteins Associated with Neurodegeneration
por: Tsoi, Phoebe S., et al.
Publicado: (2023)

Acetylation Disfavors Tau Phase Separation
por: Ferreon, Josephine C., et al.
Publicado: (2018)

Visualizing a one-way protein encounter complex by ultrafast single-molecule mixing
por: Gambin, Yann, et al.
Publicado: (2011)

Liquid condensation of reprogramming factor KLF4 with DNA provides a mechanism for chromatin organization
por: Sharma, Rajesh, et al.
Publicado: (2021)

NANOG prion-like assembly mediates DNA bridging to facilitate chromatin reorganization and activation of pluripotency
por: Choi, Kyoung-Jae, et al.
Publicado: (2022)

Glycan recognition in globally dominant human rotaviruses
por: Hu, Liya, et al.
Publicado: (2018)

DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson’s Individuals with GBA1 Mutations
por: Smith, Adam R., et al.
Publicado: (2023)

Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
por: Longhena, Francesca, et al.
Publicado: (2018)

The H50Q Mutation Induces a 10-fold Decrease in the Solubility of α-Synuclein
por: Porcari, Riccardo, et al.
Publicado: (2015)

The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson’s disease
por: Shi, Jihua, et al.
Publicado: (2023)

α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism
por: Rodríguez-Leyva, Ildefonso, et al.
Publicado: (2014)

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019)

Saturation mutagenesis of α-synuclein reveals monomer fold that modulates aggregation
por: Chlebowicz, Julita, et al.
Publicado: (2023)

Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson’s disease patients
por: Kang, Wenyan, et al.
Publicado: (2016)

α - synuclein and Parkinson’s disease: the first roadblock
por: Lin Chua, Christelle En, et al.
Publicado: (2006)

Immunological features of α-synuclein in Parkinson's disease
por: Roodveldt, Cintia, et al.
Publicado: (2008)

Models of α-synuclein aggregation in Parkinson’s disease
por: Giráldez-Pérez, Rosa María, et al.
Publicado: (2014)

Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
por: Emamzadeh, Fatemeh Nouri
Publicado: (2017)

The Role of α-Synuclein Oligomers in Parkinson’s Disease
por: Du, Xiao-yu, et al.
Publicado: (2020)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Alteration of the Conformational Dynamics of a DNA Hairpin by α‐Synuclein in the Presence of Aqueous Two‐Phase Systems
por: Mukherjee, Sanjib K., et al.
Publicado: (2020)

Does TRODAT-1 SPECT Uptake Correlate with Cerebrospinal Fluid α-Synuclein Levels in Mid-Stage Parkinson’s Disease?
por: Coutinho, Artur M., et al.
Publicado: (2023)

Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
por: Matsuo, Yasuhiro, et al.
Publicado: (2010)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
por: Huang, Yue, et al.
Publicado: (2012)

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls
por: Smith, Lynnae M., et al.
Publicado: (2012)

α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
por: Bartels, Tim, et al.
Publicado: (2011)

Exploring the Structural Diversity in Inhibitors of α-Synuclein Amyloidogenic Folding, Aggregation, and Neurotoxicity
por: Das, Sukanya, et al.
Publicado: (2018)

Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
por: Shaltiel-Karyo, Ronit, et al.
Publicado: (2010)

Optical Structural Analysis of Individual α‐Synuclein Oligomers
por: Varela, Juan A., et al.
Publicado: (2018)

The Molecular Basis of the Interaction of Cyclophilin A with α‐Synuclein
por: Favretto, Filippo, et al.
Publicado: (2020)

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
por: Winslow, Ashley R., et al.
Publicado: (2010)

Copper(II) Binding to α-Synuclein, the Parkinson’s Protein
por: Lee, Jennifer C., et al.
Publicado: (2008)

The Contribution of α-Synuclein Spreading to Parkinson's Disease Synaptopathy
por: Longhena, Francesca, et al.
Publicado: (2017)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
por: Ray, Bipul, et al.
Publicado: (2021)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
por: Jakova, Elisabet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_re95neoa0a6rolk1144s9pgk8r